CN Stock MarketDetailed Quotes

Beijing Beilu Pharmaceutical (300016)

Watchlist
  • 10.18
  • +0.06+0.59%
Market Closed Apr 10 15:00 CST
5.73BMarket Cap172.54P/E (TTM)

Beijing Beilu Pharmaceutical (300016) Revenue Breakdown Overview

By Product

Currency:CNY
2025/H1
Stock NameRevenueRatio
Contrast agent338.88M58.01%
Chinese patent medicine118.19M20.23%
Hypoglycemic drug68.22M11.68%
Total special adjustments49.11M8.41%
Other business9.81M1.68%

By Industry

Currency:CNY
2024/FY
Stock NameRevenueRatio
Drug sales972.51M98.88%
Other11.04M1.12%

By Country/Region

Currency:CNY
2024/FY
Stock NameRevenueRatio
East China region245.15M24.92%
North China164.92M16.77%
Overseas132.16M13.44%
South China129.78M13.19%
Central China125.45M12.75%
Southwest area80.75M8.21%
Northeast area75.05M7.63%
Northwest region19.26M1.96%
Other11.04M1.12%
View all

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Market Insights
Middle East conflict spreads to the stock market! How should investors respond?
On April 12 local time, U.S. Vice President Vance stated that negotiations between the United States and Iran failed to reach an agreement, Show More